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The immune system possesses the ability to recognize and 
regulate the development of tumours. Adaptive Immune 
responses play a central in tumour immune surveillance, in 
particular T-cells secreting interferon-gamma (IFN-ɣ). 
However, tumour cells can breach the host's immune system 
in a multitude of ways: IFN-ɣ resistance, reduction of antigen 
expression, loss of MHC’s and /or the production of 
immuno-inhibitory ligands  (Dunn et al 2004). 
Cancers can utilize the expression of cell surface ligands to 
evade the immune system. Here we investigate the effect of 
IFN-ɣ and polyphenols on Programmed Cell Death-Ligand 1 
(PD-L1), which is believed to help cancers cell evade the 
immune system. PD-L1 is a ligand that has been shown to 
inhibit immune responses via the Programmed Cell Death-1 
receptor on T-cells (Figure  1) (Juneja et al 2017). We are also 
interested to observe the effects of IFN-ɣ and polyphenols 
on other cellular processes such as cell cycle and apoptosis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cell culture - Patient matched Primary adenocarcinoma 
SW480 and metastatic SW620 human colorectal cancer 
(CRC) cell lines were cultured in DMEM supplemented with 
10% (v/v) fetal calf serum and 100 μg/ml Penicillin-
streptomycin and maintained at 37˚C with 5% CO2. 
Cell surface staining - PD-L1 was fluorescently stained using 
anti-human PD-L1 APC antibodies and assessed by flow 
cytomtery (BD FACs Calibur) data was analyzed using FlowJo 
software. 
Cell cycle analysis  - Cell cycle analyses were performed on 
both colorectal cell lines using propidium iodide staining and 
flow cytometry. Data was analyzed using the Deans-Jetts-Fox 
model and manually set gates. 
Cell titre glo assay  - Cells were incubated with 20ng/ml of 
IFN-ɣ, 0-500 µM of apigenin and 0-500 µM of quercetin for 
24 hrs. Treatment data was normalized to the 0.1% ethanol 
vehicle controls which was assigned 100% cell viability.  
Statistical assessment - Normality of all data sets was 
statistically analysed by a Shapiro-Wilk test. Statistical 
assessment was made using a Kruskal-Wallis with a Conover 
Inman post hoc test. Results were considered statistically 
significant when P < 0.05.  
 
 
Interferon-gamma induces PD-L1 in SW480 & SW620 
CRC cell lines 
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Figure 2: (A) Representation of gated SW480 cells and PD-L1 expression 
histograms. (B) Both SW480 and SW620 cells were incubated with 20 ng/ml 
of IFN-ɣ for 24, 48 and 72 hours, and the median fluorescent intensity (MFI) 
were compared against the MFI of unstimulated cells (Control). Treatments 
were run in triplicate in two independent experiments; data is expressed as 
mean ± standard deviation. Statistical significance was set at P<0.05 and is 
denoted '*'. 
Figure 5: Cell cycle distribution was analysed at 24, 48 and 72 hrs after 
treatment of vehicle control, IFN-ɣ 20ng/ml, apigenin (Api) 25 µM or IFN-ɣ 
20ng/ml + apigenin 25 µM (IFN-ɣ + Api). Analysis is representative of 
triplicate wells, each bar represents mean ± standard deviation, symbol '*' 
denotes statistical significance (P<0.05). 
Figure 4: The effect of apigenin and quercetin on the ATP levels as a measure 
of cell viability in SW480 and SW620 cells after 24 hours; evaluated by cell 
titre glo assay. Data was normalised to the vehicle control (VC) mean which 
was assigned 100% cell viability. Data expressed as median and ranges. 
Statistical significance was determined by comparison with the vehicle 
control, and statistical significance was set at P<0.05 which was determined 
as the lowest significant dose. 
Results 
Introduction 
Methods 
Conclusions 
Future research 
References 
With funding from the British society of immunology we are 
looking to continue researching the combination effect of 
IFN-ɣ and apigenin on PD-L1 expression, apoptosis and 
further cell cycle analysis. 
 
Apigenin has been shown to be an inhibitor of STAT1 and 
STAT3 (Hui-Hui Cao, et al 2016), so we hypothesize that 
apigenin may be able to reduce the level of PD-L1 induced by 
IFN-ɣ. 
 
Gated SW480 cells  
A 
B 
We found that IFN-ɣ 20ng/ml is a sufficient dose to stimulate 
the increased expression of PD-L1 in both the primary and 
metastatic human colorectal cancer cell lines. This 
upregulation of PD-L1 in response to IFN-ɣ stimulation is a 
strategy for the CRC cells to evade the immune system. The 
same dose of IFN-ɣ however was not significant enough too 
effect the cell cycle or cell viability of the either SW480 or 
SW620 cell lines. 
 
The polyphenol apigenin  displayed a significantly lower 
significant dose in the SW480 cell line than quercetin, 
although had no apparent effect on the metastatic SW620 
cell line. However, quercetin did lower ATP production in the 
SW620 cell line at 250 μM. These data suggest the two 
polyphenols have potential anti-cancer properties, however, 
apigenin has shown to be more potent in the primary SW480 
cell line. Polyphenols could be considered as effective 
adjuvants to immunotherapies . 
Figure 3: Cell cycle distribution was analysed at 24, 48 and 72 hrs when 
unstimulated or treated with IFN-ɣ 20ng/ml. Analysis is representative of 
triplicate wells, each bar represents mean ± standard deviation, symbol '*' 
denotes statistical significance (P<0.05). 
IFN-ɣ induced a significant upregulation of  PD-L1 expression 
on the primary and metastatic colorectal cell lines after 24 
hrs  compared to unstimulated controls (Figure 2).  
 
Preliminary data of the effect of  interferon-gamma 
primary and metastatic CRC cell cycle progression 
IFN-ɣ stimulation resulted in significant S phase 
accumulation and G1 reduction at 24hrs in SW480 cells. 
Additionally, IFN-ɣ stimulation caused significant S phase 
and G2/M phase accumulation and G1 reduction at 72 hrs 
in SW480 cells. However, no significant effects were 
observed in the SW620 cell line when stimulated with IFN-ɣ 
(Figure 3). 
 
Due to these findings, we wanted to investigate if 
polyphenols could enhance the effect IFN-ɣ on cell cycle  
and other cellular processes as they have be shown to affect 
cycle in previous work. 
 
The effect of the polyphenols apigenin and quercetin 
on ATP levels/cell viability 
Apigenin alone and in combination caused significant G2/M 
phase accumulation and G1 phase reduction in the SW620  
cell line at 24hrs. The same effect was seen again at 48hrs in 
both the SW480 and SW620 cell lines (Figure 5). 
 
IFN-ɣ displayed little to no significant effect on either of the 
SW480 or SW620 cell lines. Apigenin causes G2/M arrest but 
does not work synergistically with interferon-gamma. 
 
Apigenin displayed a lowest significant dose of 25 μM in the 
primary SW480 CRC cells (Figure 4A) but no effect was seen 
in the metastatic SW620 CRC cells when treated with a dose 
up to 500 μM (Figure 4B). 
 
Quercetin displayed a lowest significant dose of 250 μM for 
both CRC cell lines (Figure 4C & 4B). 
 
Apigenin was chosen for further experimentation as it had 
the most physiologically relevant lowest significant dose.  
The effect of combination treatment of IFN-ɣ and 
apigenin on cell cycle progression 
Figure 1: A simplified signally pathway of the induction of PD-L1 by IFN-ɣ 
and the subsequent immuno-inhibitory response. 
